ARS Pharmaceuticals CEO Laura Shawver's 2021 pay falls 94% to $822K
ARS Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: April 28, 2022
ARS Pharmaceuticals reported fiscal year 2021 executive compensation information on April 28, 2022.
In 2021, three executives at ARS Pharmaceuticals received on average a compensation package of $689K, a 90% decrease compared to previous year.
Average pay of disclosed executives at ARS Pharmaceuticals
Laura Shawver, Chief Executive Officer, received $822K in total, which decreased by 94% compared to 2020. 65% of Shawver's compensation, or $530K, was in salary. Shawver also received $292K in non-equity incentive plan.
Valerie Odegard, Chief Scientific Officer, received a compensation package of $634K, which decreased by 91% compared to previous year. 69% of the compensation package, or $440K, was in salary.
Jonathan Piazza, Chief Financial Officer, earned $612K in 2021, a 90% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2022.